> Koledzy nie słyszeli, że malaria może wejść w fazę przewlekłą i zarodźce
> będą dawać nawroty „do końca życia”?!
> Jeśli goście pisali tendencyjny abstrakt, aby wywrzeć maksymalnie wielkie wraże
> nie sukcesu, to niech się liczą z tym, że ich abstrakt przywołuje wspomnienie o
> Dr Mengele i spółka też zarażali w sposób KONTROLOWANY.
To chore, co piszesz.
„Malaria-naïve, healthy adults, 18-45 years of age with a negative sickle cell screening test, were included. Additional volunteers who were not immunized were recruited for CHMI as controls.”
VRC 312 was approved by the Intramural Institutional Review Board (IRB) of the
National Institute of Allergy and Infectious Diseases (NIAID). U.S. Department of
Health and Human Services guidelines for conducting clinical research were followed.
The first 3 subjects/dosage group were enrolled on separate days and evaluated until one
week after second vaccination to assess safety prior to dose escalation or enrollment of
the remaining cohort at that dose level. Each step was reviewed and approved by a Safety
3 Monitoring Committee and submitted to the Food and Drug Administration (FDA).
The protocol was reviewed by FDA and conducted under IND 14826
Subjects [in CHMI – kornel] were discharged after two consecutive days with negative malaria smears or on post – CHMI day 18 if not parasitemic.